Beaird Harris Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7
Closed -$760 714
2024
Q2
$760 Sell
7
-56
-89% -$6.6K ﹤0.01% 609
2024
Q1
$8.31K Sell
63
-16
-20% -$2K ﹤0.01% 342
2023
Q4
$9.62K Buy
79
+72
+1,029% +$8.03K ﹤0.01% 329
2023
Q3
$786 Hold
7
﹤0.01% 402
2023
Q2
$1.02K Hold
7
﹤0.01% 397
2023
Q1
$905 Sell
7
-71
-91% -$8.91K ﹤0.01% 415
2022
Q4
$9.95K Buy
78
+71
+1,014% +$8.24K ﹤0.01% 324
2022
Q3
$1K Buy
+7
New +$768 ﹤0.01% 473
2022
Q2
Sell
-64
Closed -$8K 638
2022
Q1
$8K Sell
64
-252
-80% -$30.4K ﹤0.01% 375
2021
Q4
$39K Buy
+316
New +$41.4K 0.01% 264

Other funds holding ZBH

Beaird Harris Wealth Management's ZBH Position: Q3 2024 in Review

Beaird Harris Wealth Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 7 shares — an estimated $760 sold.

Beaird Harris Wealth Management first reported a position in ZBH in Q4 2021 and held it in 10 quarters. The position peaked at $39K in Q4 2021. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Beaird Harris Wealth Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 7 Zimmer Biomet shares in Q3 2024, an estimated $760.
  • Beaird Harris Wealth Management first reported a position in Zimmer Biomet in Q4 2021 and held it in 10 quarters.
  • Beaird Harris Wealth Management's Zimmer Biomet position peaked at $39K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q3 2024, filed 2 Dec 2024.